News >

Robotic Approaches Advancing Surgical Scope in Muscle-Invasive Bladder Cancer

Caroline Seymour
Published: Wednesday, Feb 07, 2018

William C. Huang, MD,

William C. Huang, MD
Preliminary findings from an ongoing study have demonstrated efficacy and quality-of-life benefits associated with robotic-assisted cystectomy in patients with muscle-invasive bladder cancer, pointing to a potential shift in current practice.

The ongoing randomized phase III RAZOR trial is comparing open radical cystectomy (ORC) with robotic-assisted radial cystectomy (RARC) in patients with stage T1-T4, N0-N1, M0 bladder cancer. The study has a noninferiority endpoint, as well as blood transfusion rate, estimated blood loss, length of stay, complications, lymph node yield, and margin status.

... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: How Can We Optimize Outcomes in Head and Neck Cancers with Immunotherapeutic Strategies?Oct 31, 20191.5
The Patient and Provider Connection™: Effective Communication to Optimize the Diagnosis and Management of Irritable Bowel Syndrome and Chronic Idiopathic ConstipationOct 31, 20191.0
Publication Bottom Border
Border Publication